<span id="ldtbo"></span>

<track id="ldtbo"><div id="ldtbo"></div></track>
    <tbody id="ldtbo"></tbody>

      1. <tbody id="ldtbo"><nobr id="ldtbo"><address id="ldtbo"></address></nobr></tbody>
      2. <option id="ldtbo"><div id="ldtbo"></div></option>
      3. <track id="ldtbo"></track>

          <menuitem id="ldtbo"></menuitem><bdo id="ldtbo"></bdo>
        1. <tbody id="ldtbo"><div id="ldtbo"><td id="ldtbo"></td></div></tbody>

            <track id="ldtbo"></track>
            Filter By:
            • News
              April 12, 2018

              Doravirine Effective in Treatment-naive Adults With HIV

              A study comparing the efficacy of doravirine and ritonavir-boosted darunavir in adult patients with HIV who were treatment-naive found that doravirine was …

              Read Article
            • News
              April 10, 2018

              Record Number Of Specialty Pharmacies Now Have Accreditation

              The number of accredited specialty pharmacies nearly doubled between 2015 and 2017, according to research by the Drug Channels Institute. The fastest-growi…

              Read Article
            • News
              April 09, 2018

              Pharmacists Can Improve Outcomes

              Pharmacists can improve optimization of medication therapies to improve outcomes and reduce costs. Strategies include allowing pharmacist access to complet…

              Read Article
            • News
              March 22, 2018

              Cimzia Label Update Provides New Information For Women Of Childbearing Age

              The FDA approved a label update of UCB's Cimzia, or certolizumab pegol, to include new data showing a negligible to low risk for drug transfer through plac…

              Read Article
            • News
              March 05, 2018

              Review Finds Switching From Reference Product To Biosimilar ‘Not Inherently Dangerous’

              A review in the journal Drugs found that moving to a biosimilar from a reference drug "is not inherently dangerous, and that patients, healthcare professio…

              Read Article
            • News
              February 13, 2018

              Novartis Gains U.S. Approval For Glatopa For Multiple Sclerosis

              Novartis's Sandoz division has won U.S. approval for a larger dose of its Glatops drug for multiple sclerosis (MS). Click Here to view the original arti…

              Read Article

            A smaller focus to make a much larger impact. Our goal is to deliver on every promise we make

            Our Mission

            Learn More